GP Act Valuation
| GPAT Stock | 10.75 0.02 0.19% |
At this time, the firm appears to be overvalued. GP Act III owns a latest Real Value of USD9.01 per share. The recent price of the firm is USD10.75. Our model calculates the value of GP Act III from inspecting the firm fundamentals such as Return On Asset of -0.0014, price to book of 1.32 X, and Shares Outstanding of 28.75 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that GP Act's price fluctuation is very steady at this time. Calculation of the real value of GP Act III is based on 3 months time horizon. Increasing GP Act's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
GP Act's intrinsic value may or may not be the same as its current market price of 10.75, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.75 | Real 9.01 | Hype 10.75 |
The intrinsic value of GP Act's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GP Act's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GP Act III Acquisition helps investors to forecast how GPAT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GP Act more accurately as focusing exclusively on GP Act's fundamentals will not take into account other important factors: GP Act Cash |
|
About GP Act Valuation
The stock valuation mechanism determines GP Act's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of GP Act III based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of GP Act. We calculate exposure to GP Act's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GP Act's related companies.GP Act Growth Indicators
Investing in growth stocks can be very risky. If the company such as GP Act does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 18.3 M | |
| Quarterly Earnings Growth Y O Y | -0.151 | |
| Shares Float | 28.8 M |
GP Act Current Valuation Indicators
GP Act's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final GP Act's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as GP Act, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use GP Act's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes GP Act's worth.Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.